31. Assessment of the telomere length and its effect on the symptomatology of Parkinson's diseaseTina Levstek, Sara Redenšek Trampuž, Maja Trošt, Vita Dolžan, Katarina Trebušak Podkrajšek, 2021, original scientific article Keywords: Parkinson's disease, telomere length, levodopa treatment, telomere attrition, dementia Full text (file, 737,20 KB) This document has more files! More... |
32. CARD8 and IL1B polymorphisms influence MRI brain patterns in newborns with hypoxic-ischemic encephalopathy treated with hypothermiaKatarina Esih, Katja Goričar, Zvonka Rener-Primec, Vita Dolžan, Aneta Soltirovska Šalamon, 2021, original scientific article Keywords: hypoxic-ischemic encephalopathy, inflammation, newborn, oxidative stress, polymorphism, MRI Full text (file, 310,24 KB) This document has more files! More... |
33. Clinical pharmacogenetic models of treatment response to methotrexate monotherapy in Slovenian and Serbian rheumatoid arthritis patientsBarbara Jenko Bizjan, Matija Tomšič, Biljana Jekić, Vera Milić, Vita Dolžan, Sonja Praprotnik, 2018, original scientific article Keywords: rheumatoid arthritis, pharmacogenetics, methotrexate, polymorphism, predictive model Full text (file, 372,15 KB) This document has more files! More... |
34. Genetic variability in antioxidative and inflammatory pathways modifies the risk for PCOS and influences metabolic profile of the syndromeRok Herman, Mojca Jensterle Sever, Andrej Janež, Katja Goričar, Vita Dolžan, 2020, original scientific article Keywords: polycystic ovary syndrome, genetic variability, oxidative stress, inflammation, metabolic profile Full text (file, 1,14 MB) This document has more files! More... |
35. Extracellular vesiclesKatja Goričar, Vita Dolžan, Metka Lenassi, 2021, review article Keywords: pharmacogenomics, cancer, personalized medicine, extracellular vesicle, liquid biopsy, biomarker Full text (file, 1,04 MB) This document has more files! More... |
|
|
38. Genetic variability of the vitamin D receptor affects susceptibility to Parkinson's disease and dopaminergic treatment adverse eventsSara Redenšek Trampuž, Tilen Kristanc, Tanja Blagus, Maja Trošt, Vita Dolžan, 2022, original scientific article Keywords: vitamin D receptor, Parkinson’s disease, biomarker, risk, susceptibility, adverse events, vitamin D, polymorphism Full text (file, 279,78 KB) This document has more files! More... |
39. Genetic polymorphisms in oxidative stress and inflammatory pathways as potential biomarkers in Alzheimer’s disease and dementiaDavid Vogrinc, Milica Gregorič Kramberger, Andreja Emeršič, Saša Čučnik, Katja Goričar, Vita Dolžan, 2023, original scientific article Keywords: Alzheimer’s disease, oxidative stress, inflammation, polymorphism, biomarker Full text (file, 1,14 MB) This document has more files! More... |
40. Investigation of paraoxonase-1 genotype and enzyme-kinetic parameters in the context of cognitive impairment in Parkinson’s diseaseBoštjan Petrič, Sara Redenšek Trampuž, Vita Dolžan, Milica Gregorič Kramberger, Maja Trošt, Nikola Maraković, Marko Goličnik, Aljoša Bavec, 2023, original scientific article Keywords: Parkinson disease, cognitive impairment, paraoxonase 1, paraoxonase activity, single-nucleotide polymorphisms, iFIT Full text (file, 1,14 MB) This document has more files! More... |